{"entity":{"type":"insider","cik":"0001590001","url":"/insider/0001590001","json_url":"/insider/0001590001.json","name":"Kopczynski Casey C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":11,"first":"2018-05-29","last":"2020-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Kopczynski Casey C.","source":"filing","n_filings":11,"first_seen":"2018-05-29","last_seen":"2020-11-12"}],"transactions":[{"id":2252412,"accession":"0001209191-20-058021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058021","line_url":"/filing/0001209191-20-058021#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22695.0,"shares_display":"22,695","price_per_share":13.0077,"price_display":"13.01","price_state":"stated","total_value":295209.7515,"total_display":"295,209.75","total_whole":"295,210","shares_owned_after":196114.0,"shares_owned_after_display":"196,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2252408,"accession":"0001209191-20-058021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058021","line_url":"/filing/0001209191-20-058021#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7305.0,"shares_display":"7,305","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":94965.0,"total_display":"94,965.00","total_whole":"94,965","shares_owned_after":218809.0,"shares_owned_after_display":"218,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":8723907,"accession":"0001209191-19-006625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-006625","line_url":"/filing/0001209191-19-006625","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":46.16759090909091,"price_display":"46.17","price_state":"stated","total_value":507843.5,"total_display":"507,843.50","total_whole":"507,844","shares_owned_after":97243.0,"shares_owned_after_display":"97,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-01","scope":"insider","n_lines":2},{"id":8594414,"accession":"0001209191-19-000224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-000224","line_url":"/filing/0001209191-19-000224#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":35.2103,"price_display":"35.21","price_state":"stated","total_value":387313.3,"total_display":"387,313.30","total_whole":"387,313","shares_owned_after":106743.0,"shares_owned_after_display":"106,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-02","scope":"insider"},{"id":6914164,"accession":"0001209191-18-060814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-060814","line_url":"/filing/0001209191-18-060814","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":39.80851740909091,"price_display":"39.81","price_state":"stated","total_value":437893.6915,"total_display":"437,893.69","total_whole":"437,894","shares_owned_after":118042.0,"shares_owned_after_display":"118,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-04","scope":"insider","n_lines":2},{"id":5966464,"accession":"0001209191-18-056910","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-056910","line_url":"/filing/0001209191-18-056910","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":53.8655248,"price_display":"53.87","price_state":"stated","total_value":592520.7728,"total_display":"592,520.77","total_whole":"592,521","shares_owned_after":128743.0,"shares_owned_after_display":"128,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-02","scope":"insider","n_lines":2},{"id":6337565,"accession":"0001209191-18-052854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-052854","line_url":"/filing/0001209191-18-052854","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":60.56399481818182,"price_display":"60.56","price_state":"stated","total_value":666203.943,"total_display":"666,203.94","total_whole":"666,204","shares_owned_after":138187.0,"shares_owned_after_display":"138,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-01","scope":"insider","n_lines":2},{"id":6478958,"accession":"0001209191-18-049864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-049864","line_url":"/filing/0001209191-18-049864","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":60.09309090909091,"price_display":"60.09","price_state":"stated","total_value":661024.0,"total_display":"661,024.00","total_whole":"661,024","shares_owned_after":148517.0,"shares_owned_after_display":"148,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider","n_lines":2},{"id":6336791,"accession":"0001209191-18-044921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-044921","line_url":"/filing/0001209191-18-044921","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":68.29981545454545,"price_display":"68.30","price_state":"stated","total_value":751297.97,"total_display":"751,297.97","total_whole":"751,298","shares_owned_after":163307.0,"shares_owned_after_display":"163,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-02","scope":"insider","n_lines":2},{"id":5965190,"accession":"0001209191-18-041534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-041534","line_url":"/filing/0001209191-18-041534","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":66.36944181818181,"price_display":"66.37","price_state":"stated","total_value":730063.86,"total_display":"730,063.86","total_whole":"730,064","shares_owned_after":172117.0,"shares_owned_after_display":"172,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider","n_lines":2},{"id":6519743,"accession":"0001209191-18-036804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036804","line_url":"/filing/0001209191-18-036804","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":58.74878181818182,"price_display":"58.75","price_state":"stated","total_value":646236.6,"total_display":"646,236.60","total_whole":"646,237","shares_owned_after":183517.0,"shares_owned_after_display":"183,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider","n_lines":2},{"id":6660282,"accession":"0001209191-18-033936","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-033936","line_url":"/filing/0001209191-18-033936#line-3","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001590001","owner_name":"Kopczynski Casey C.","owner_display_name":"Kopczynski Casey C.","owner_url":"/insider/0001590001","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2708.0,"shares_display":"2,708","price_per_share":50.15,"price_display":"50.15","price_state":"stated","total_value":135806.2,"total_display":"135,806.20","total_whole":"135,806","shares_owned_after":191517.0,"shares_owned_after_display":"191,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Officer (Chief Scientific Officer)","n_filings":11,"first_seen":"2018-05-29","last_seen":"2020-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001590001","retrieved_at":"2026-08-25T11:45:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}